Ninety One Uk LTD Gilead Sciences, Inc. Transaction History

Ninety One Uk LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $7.05 Million - $8.18 Million	-97,422 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $6.1 Million - $7.82 Million	97,422 New	97,422 $7.28 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $312,237 - $344,655	-4,995 Closed	0 $0
Q2 2019 Jul 30, 2019	SELL	$61.87 - $69.38 $34,956 - $39,199	-565 Reduced 10.16%	4,995 $337,000
Q1 2019 Apr 24, 2019	BUY	$62.53 - $70.05 $58,215 - $65,216	931 Added 20.11%	5,560 $361,000
Q4 2018 Feb 08, 2019	BUY	$60.54 - $79.0 $280,239 - $365,691	4,629 New	4,629 $290,000
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $5.67 Million - $6.61 Million	-87,345 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $8,012 - $9,768	-110 Reduced 0.13%	87,345 $6.59 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $273,073 - $320,549	-3,838 Reduced 4.2%	87,455 $6.27 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $6.58 Million - $7.8 Million	91,293	91,293 $7.4 Million

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ninety One Uk LTD, based on Form 13F filings with the SEC.

Stay updated on Ninety One Uk LTD with notifications on news.